Fig. 5From: IBIS: identify biomarker-based subgroups with a Bayesian enrichment design for targeted combination therapySimulated average width of 95% CI of treatment effect estimates for 12 subgroups under eight scenarios using ‘IBIS’, ‘Independent Analysis’ and ‘BHM’. CI means credible interval in ‘IBIS’ and ‘BHM’ method, while it means confidence interval in ‘Independent Analysis’Back to article page